<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 22 Jul 2026 16:02:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</link>
   <description>
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.maravai.com%2F&amp;amp;esheet=54575171&amp;amp;newsitemid=20260722280331&amp;amp;lan=en-US&amp;amp;anchor=Maravai+LifeSciences%2C+Inc.&amp;amp;index=1&amp;amp;md5=779b4397933aa37b552e1c726ad4eec1&quot; shape=&quot;rect&quot;&gt;Maravai LifeSciences, Inc.&lt;/a&gt; (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter financial and operating results after the market close on Thursday, August 6, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

&lt;/p&gt;&lt;p&gt;
To participate in the conference call by telephone, dial 1-800-579-2543 or 1-785-424-1789 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the &quot;Investors&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</guid>
   <pubDate>Wed, 22 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213487</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.17591063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</link>
   <description>
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.maravai.com%2F&amp;amp;esheet=54575171&amp;amp;newsitemid=20260722280331&amp;amp;lan=en-US&amp;amp;anchor=Maravai+LifeSciences%2C+Inc.&amp;amp;index=1&amp;amp;md5=779b4397933aa37b552e1c726ad4eec1&quot; shape=&quot;rect&quot;&gt;Maravai LifeSciences, Inc.&lt;/a&gt; (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter financial and operating results after the market close on Thursday, August 6, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

&lt;/p&gt;&lt;p&gt;
To participate in the conference call by telephone, dial 1-800-579-2543 or 1-785-424-1789 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the &quot;Investors&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</guid>
   <pubDate>Wed, 22 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213487</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.17591063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</link>
   <description>
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.maravai.com%2F&amp;amp;esheet=54575171&amp;amp;newsitemid=20260722280331&amp;amp;lan=en-US&amp;amp;anchor=Maravai+LifeSciences%2C+Inc.&amp;amp;index=1&amp;amp;md5=779b4397933aa37b552e1c726ad4eec1&quot; shape=&quot;rect&quot;&gt;Maravai LifeSciences, Inc.&lt;/a&gt; (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter financial and operating results after the market close on Thursday, August 6, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

&lt;/p&gt;&lt;p&gt;
To participate in the conference call by telephone, dial 1-800-579-2543 or 1-785-424-1789 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the &quot;Investors&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</guid>
   <pubDate>Wed, 22 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213487</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.17591063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</link>
   <description>
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.maravai.com%2F&amp;amp;esheet=54575171&amp;amp;newsitemid=20260722280331&amp;amp;lan=en-US&amp;amp;anchor=Maravai+LifeSciences%2C+Inc.&amp;amp;index=1&amp;amp;md5=779b4397933aa37b552e1c726ad4eec1&quot; shape=&quot;rect&quot;&gt;Maravai LifeSciences, Inc.&lt;/a&gt; (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter financial and operating results after the market close on Thursday, August 6, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

&lt;/p&gt;&lt;p&gt;
To participate in the conference call by telephone, dial 1-800-579-2543 or 1-785-424-1789 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the &quot;Investors&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</guid>
   <pubDate>Wed, 22 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213487</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.17591063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026</title>
   <link>http://www.streetinsider.com/Business+Wire/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</link>
   <description>
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.maravai.com%2F&amp;amp;esheet=54575171&amp;amp;newsitemid=20260722280331&amp;amp;lan=en-US&amp;amp;anchor=Maravai+LifeSciences%2C+Inc.&amp;amp;index=1&amp;amp;md5=779b4397933aa37b552e1c726ad4eec1&quot; shape=&quot;rect&quot;&gt;Maravai LifeSciences, Inc.&lt;/a&gt; (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter financial and operating results after the market close on Thursday, August 6, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

&lt;/p&gt;&lt;p&gt;
To participate in the conference call by telephone, dial 1-800-579-2543 or 1-785-424-1789 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the &quot;Investors&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</guid>
   <pubDate>Wed, 22 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213487</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.17591063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026</title>
   <link>http://www.streetinsider.com/Business+Wire/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</link>
   <description>
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.maravai.com%2F&amp;amp;esheet=54575171&amp;amp;newsitemid=20260722280331&amp;amp;lan=en-US&amp;amp;anchor=Maravai+LifeSciences%2C+Inc.&amp;amp;index=1&amp;amp;md5=779b4397933aa37b552e1c726ad4eec1&quot; shape=&quot;rect&quot;&gt;Maravai LifeSciences, Inc.&lt;/a&gt; (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter financial and operating results after the market close on Thursday, August 6, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

&lt;/p&gt;&lt;p&gt;
To participate in the conference call by telephone, dial 1-800-579-2543 or 1-785-424-1789 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the &quot;Investors&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</guid>
   <pubDate>Wed, 22 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213487</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.17591063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026</title>
   <link>http://www.streetinsider.com/Business+Wire/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</link>
   <description>
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.maravai.com%2F&amp;amp;esheet=54575171&amp;amp;newsitemid=20260722280331&amp;amp;lan=en-US&amp;amp;anchor=Maravai+LifeSciences%2C+Inc.&amp;amp;index=1&amp;amp;md5=779b4397933aa37b552e1c726ad4eec1&quot; shape=&quot;rect&quot;&gt;Maravai LifeSciences, Inc.&lt;/a&gt; (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter financial and operating results after the market close on Thursday, August 6, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

&lt;/p&gt;&lt;p&gt;
To participate in the conference call by telephone, dial 1-800-579-2543 or 1-785-424-1789 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the &quot;Investors&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</guid>
   <pubDate>Wed, 22 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213487</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.17591063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026</title>
   <link>http://www.streetinsider.com/Business+Wire/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</link>
   <description>
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.maravai.com%2F&amp;amp;esheet=54575171&amp;amp;newsitemid=20260722280331&amp;amp;lan=en-US&amp;amp;anchor=Maravai+LifeSciences%2C+Inc.&amp;amp;index=1&amp;amp;md5=779b4397933aa37b552e1c726ad4eec1&quot; shape=&quot;rect&quot;&gt;Maravai LifeSciences, Inc.&lt;/a&gt; (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter financial and operating results after the market close on Thursday, August 6, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

&lt;/p&gt;&lt;p&gt;
To participate in the conference call by telephone, dial 1-800-579-2543 or 1-785-424-1789 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the &quot;Investors&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Maravai+LifeSciences+To+Host+Earnings+Conference+Call+on+Thursday%2C+August+6%2C+2026/26801513.html</guid>
   <pubDate>Wed, 22 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213487</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.17591063</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>TriLink BioTechnologies receives China patent for CleanCap technology</title>
   <link>http://www.streetinsider.com/Corporate+News/TriLink+BioTechnologies+receives+China+patent+for+CleanCap+technology/26789644.html</link>
   <description>&lt;p&gt;TriLink BioTechnologies, LLC, a subsidiary of Maravai LifeSciences (NASDAQ: MRVI), has been granted a patent by China's National Intellectual Property Administration (CNIPA) covering methods of synthesizing RNA molecules using its CleanCap capping analogs.&lt;/p&gt;&lt;p&gt;The patent, numbered ZL 2025 1 1246578.X, covers TriLink's full suite of CleanCap capping analogs, including its M6 analog. The allowed claims are directed to co-transcriptional RNA synthesis methods utilizing trimer or tetramer capping structures.&lt;/p&gt;&lt;p&gt;According to the company, CleanCap technology is now patented in China, the United States, the European Union, Australia, Japan, Korea, Hong Kong, and Canada. TriLink describes itself as the sole authorized manufacturer of CleanCap</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/TriLink+BioTechnologies+receives+China+patent+for+CleanCap+technology/26789644.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:02:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	  </item>
  <item>
   <title>TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology</title>
   <link>http://www.streetinsider.com/Press+Releases/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;TriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL 2025 1 1246578.X, covering methods of synthesizing RNA molecules. The new patent covers TriLink's full suite of CleanCap® capping analogs, including its latest M6 analog. CleanCap technology is a critical component of the production of synthetic mRNA</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204872</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184580</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology</title>
   <link>http://www.streetinsider.com/Press+Releases/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;TriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL 2025 1 1246578.X, covering methods of synthesizing RNA molecules. The new patent covers TriLink's full suite of CleanCap® capping analogs, including its latest M6 analog. CleanCap technology is a critical component of the production of synthetic mRNA</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204872</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184580</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology</title>
   <link>http://www.streetinsider.com/Press+Releases/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;TriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL 2025 1 1246578.X, covering methods of synthesizing RNA molecules. The new patent covers TriLink's full suite of CleanCap® capping analogs, including its latest M6 analog. CleanCap technology is a critical component of the production of synthetic mRNA</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204872</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184580</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology</title>
   <link>http://www.streetinsider.com/Press+Releases/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;TriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL 2025 1 1246578.X, covering methods of synthesizing RNA molecules. The new patent covers TriLink's full suite of CleanCap® capping analogs, including its latest M6 analog. CleanCap technology is a critical component of the production of synthetic mRNA</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204872</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184580</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology</title>
   <link>http://www.streetinsider.com/Business+Wire/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;TriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL 2025 1 1246578.X, covering methods of synthesizing RNA molecules. The new patent covers TriLink's full suite of CleanCap® capping analogs, including its latest M6 analog. CleanCap technology is a critical component of the production of synthetic mRNA</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204872</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184580</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology</title>
   <link>http://www.streetinsider.com/Business+Wire/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;TriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL 2025 1 1246578.X, covering methods of synthesizing RNA molecules. The new patent covers TriLink's full suite of CleanCap® capping analogs, including its latest M6 analog. CleanCap technology is a critical component of the production of synthetic mRNA</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204872</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184580</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology</title>
   <link>http://www.streetinsider.com/Business+Wire/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;TriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL 2025 1 1246578.X, covering methods of synthesizing RNA molecules. The new patent covers TriLink's full suite of CleanCap® capping analogs, including its latest M6 analog. CleanCap technology is a critical component of the production of synthetic mRNA</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204872</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184580</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology</title>
   <link>http://www.streetinsider.com/Business+Wire/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;TriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    SAN DIEGO--(BUSINESS WIRE)--
TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL 2025 1 1246578.X, covering methods of synthesizing RNA molecules. The new patent covers TriLink's full suite of CleanCap® capping analogs, including its latest M6 analog. CleanCap technology is a critical component of the production of synthetic mRNA</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/TriLink+BioTechnologies%C2%AE+Further+Strengthens+Global+IP+Position+with+Newly+Issued+Patent+in+China+for+CleanCap%C2%AE+Capping+Technology/26789640.html</guid>
   <pubDate>Mon, 20 Jul 2026 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50204872</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00184580</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Form  4          MARAVAI LIFESCIENCES      For: Jul 08  Filed by: Brust Bernd</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jul+08++Filed+by%3A+Brust+Bernd/26758124.html</link>
   <description>si-local-file:///var/storage/secattach/20260710/26758124.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jul+08++Filed+by%3A+Brust+Bernd/26758124.html</guid>
   <pubDate>Fri, 10 Jul 2026 17:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Form  4          MARAVAI LIFESCIENCES      For: Jul 08  Filed by: Brust Bernd</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jul+08++Filed+by%3A+Brust+Bernd/26758124.html</link>
   <description>si-local-file:///var/storage/secattach/20260710/26758124.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jul+08++Filed+by%3A+Brust+Bernd/26758124.html</guid>
   <pubDate>Fri, 10 Jul 2026 17:34:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Form  4          MARAVAI LIFESCIENCES      For: Jun 30  Filed by: Asarpota Rajesh</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+30++Filed+by%3A+Asarpota+Rajesh/26722709.html</link>
   <description>si-local-file:///var/storage/secattach/20260701/26722709.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+30++Filed+by%3A+Asarpota+Rajesh/26722709.html</guid>
   <pubDate>Wed, 01 Jul 2026 20:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Form  4          MARAVAI LIFESCIENCES      For: Jun 30  Filed by: Asarpota Rajesh</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+30++Filed+by%3A+Asarpota+Rajesh/26722709.html</link>
   <description>si-local-file:///var/storage/secattach/20260701/26722709.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MARAVAI+LIFESCIENCES++++++For%3A+Jun+30++Filed+by%3A+Asarpota+Rajesh/26722709.html</guid>
   <pubDate>Wed, 01 Jul 2026 20:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  MARAVAI LIFESCIENCES                   Filed by: MILLENNIUM MANAGEMENT LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+MILLENNIUM+MANAGEMENT+LLC/26708031.html</link>
   <description>si-local-file:///var/storage/secattach/20260629/26708031.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+MILLENNIUM+MANAGEMENT+LLC/26708031.html</guid>
   <pubDate>Mon, 29 Jun 2026 19:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  MARAVAI LIFESCIENCES                   Filed by: MILLENNIUM MANAGEMENT LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+MILLENNIUM+MANAGEMENT+LLC/26708031.html</link>
   <description>si-local-file:///var/storage/secattach/20260629/26708031.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+MILLENNIUM+MANAGEMENT+LLC/26708031.html</guid>
   <pubDate>Mon, 29 Jun 2026 19:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  MARAVAI LIFESCIENCES                   Filed by: MILLENNIUM MANAGEMENT LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+MILLENNIUM+MANAGEMENT+LLC/26680916.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26680916.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+MILLENNIUM+MANAGEMENT+LLC/26680916.html</guid>
   <pubDate>Tue, 23 Jun 2026 18:52:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  MARAVAI LIFESCIENCES                   Filed by: MILLENNIUM MANAGEMENT LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+MILLENNIUM+MANAGEMENT+LLC/26680916.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26680916.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++MARAVAI+LIFESCIENCES+++++++++++++++++++Filed+by%3A+MILLENNIUM+MANAGEMENT+LLC/26680916.html</guid>
   <pubDate>Tue, 23 Jun 2026 18:52:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MRVI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49219148</category>
   	  </item>
 </channel>
</rss>
